UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

                                 Date of Report
                       (Date of earliest event reported):

                                September 3, 2003



                                 ANTIGENICS INC.
             (Exact name of registrant as specified in its charter)

           DELAWARE                      000-29089                06-1562417

(State or other jurisdiction of   (Commission file number)    (I.R.S. Employer
incorporation of organization)                               Identification No.)


                          630 FIFTH AVENUE, SUITE 2100
                            NEW YORK, NEW YORK 10111
              (Address of principal executive offices and zip code)

                                 (212) 994-8200
              (Registrant's telephone number, including area code)






Item 5.  Other Events

      The Company issued a news release on September 3, 2003, a copy of which is
attached hereto as Exhibit 99.1.

Item 7.  Financial Statements and Exhibits.

         (c) Exhibits:

             99.1     Press Release dated September 3, 2003





                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                                                 ANTIGENICS INC.

Date: September 3, 2003                                    By: /s/ Garo H. Armen
                                                     ---------------------------

                                                            Garo H. Armen, Ph.D.
                                            Chairman and Chief Executive Officer






                                  EXHIBIT INDEX


The following designated exhibits are filed herewith:

Exhibits:

99.1                Press Release dated September 3, 2003